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Introduction
Autophagy is a general homeostatic process in eukaryotic cells 
whereby portions of the cytoplasm, containing cytosol or organ-
elles, are sequestered into double membrane-bound autophagic 
vacuoles for fusion with lysosomal organelles and subsequent 
degradation of the captured contents in the resulting autolyso-
somes (Shintani and Klionsky, 2004; Klionsky, 2007). A func-
tional  core  autophagy  pathway  and  associated  processes  are 
important for cell survival under starvation or growth factor with-
drawal conditions, programmed cell death, elimination of aggre-
gated proteins, and removal of surplus or damaged organelles 
(Levine and Klionsky, 2004; Levine and Kroemer, 2008).   
Autophagy is regulated by signaling pathways centered around the 
Ser/Thr protein kinase Tor (target of rapamycin) and phosphati-
dylinositol 3-kinases (PI3Ks), both type I (inhibitory to autoph-
agy) and type III (essential for execution of autophagy). The type 
III PI3K hVPS34 acts in a complex with Beclin 1 (yeast Atg6), a 
factor endowing hVPS34 with its role in autophagy (Pattingre   
et al., 2005). A detailed picture on these and other autophagy 
proteins (Atg) in mammalian cells is emerging, with the core 
pathway resembling that in yeast (Levine and Klionsky, 2004; 
Shintani and Klionsky, 2004; Klionsky, 2007).
Autophagosome biogenesis and wrapping around auto-
phagic targets is facilitated by the two specialized protein   
A
utophagy is a cytoplasmic degradative pathway 
that can participate in biosynthetic processes, as 
in the yeast Cvt pathway, but is more commonly 
known for its functions in removing damaged or surplus 
organelles  and  macromolecular  complexes.  Here,  we 
find  that  autophagy  intersects  with  human  immuno­
deficiency virus (HIV) biogenesis, mirroring the above 
dichotomy. Early, nondegradative stages of autophagy 
promoted  HIV  yields.  HIV  Gag­derived  proteins  co­
localized and interacted with the autophagy factor LC3,   
and autophagy promoted productive Gag processing. 
Nevertheless, when autophagy progressed through mat­
uration stages, HIV was degraded. This, however, does not 
occur, as the HIV protein Nef acts as an antiautophagic 
maturation factor through interactions with the autoph­
agy regulatory factor Beclin 1, thus protecting HIV from 
degradation.  The  dual  interaction  of  HIV  with  the   
autophagy pathway enhances viral yields by using the 
early stages while inhibiting the late stages of autoph­
agy. The role of Nef in the latter process enhances yields 
of infectious HIV and may be of significance for progres­
sion to clinical AIDS.
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CD4+ T cell activation correlates with viral pathogenesis 
(Schindler et al., 2006; Schindler et al., 2008). Our findings 
presented here uncover an additional, previously unappreciated 
Nef action in control of autophagy. Nef functions in preventing 
destruction of HIV components in autolysosomes, thus shield-
ing HIV from autophagy in its role of a cell autonomous anti-
microbial defense.
Results
Basal autophagy augments HIV yields  
in macrophages
Basal autophagy is operational in all cell types, particularly in 
mononuclear phagocytic and dendritic cells (Schmid et al., 
2007). To test whether basal autophagy can affect HIV yields, 
we pharmacologically inhibited autophagy in primary human 
macrophages differentiated from peripheral blood monocytes 
and infected with the macrophage-tropic HIV strain SF162, and 
determined  yields  of  the  infectious  virus  released  from  the   
macrophages. The macrophages treated with 3-methyl adenine 
(3MA), a conventional inhibitor of autophagy, yielded three-
fold fewer infectious virions compared with the untreated con-
trol (Fig. 1 A). The magnitude of this effect could be increased 
with higher inhibitor concentrations, but we used mild pharma-
cological and other treatments in these and subsequent experi-
ments to avoid nonspecific effects. The autophagy requirement 
for optimal HIV yields was also assessed by determining extra-
cellular release of the HIV capsid protein Gag p24 (Ono and 
Freed, 2004). The p24 released from live virus–infected pri-
mary macrophages was reduced in cells subjected to inhibition 
by 3MA (Fig. 1 B). Because pharmacological inhibitors such as 
3MA may not affect only the autophagic pathway, we ascer-
tained a role of the bona fide autophagy pathway by knocking 
down Beclin 1 (Atg6) in primary macrophages (Fig. 1, C and D) 
and in macrophages differentiated from monocytic U937 cells 
(Fig. 1, E and F). Knockdown of Beclin 1 diminished p24 yields 
in  both  primary  monocyte-  and  U937-derived  macrophages 
(Fig.1, D and F). A knockdown of another essential autophagy 
factor, Atg7, resulted in a similar effect on p24 yields (Fig. 1 F); 
Atg7 and Beclin 1 knockdowns affected autophagy in U937 
cells, as determined by GFP-LC3 puncta/cell counts (Fig. S1). 
We next examined the intracellular Gag processing by monitor-
ing  Gag-derived  p24  band  intensity  in  immunoblots  of  cell   
extracts. When U937 cells knocked down for Beclin 1 were in-
fected with vesicular stomatitis virus G (VSV-G)–pseudotyped 
NL4-3 HIV 1, cellular p24 levels were reduced compared with 
controls (Fig. 1 G). Collectively, these results indicate that basal 
autophagy promotes optimal Gag processing and yields of HIV 
in macrophages.
HIV and HIV Gag-derived proteins 
colocalize with the autophagy marker LC3
To test whether and how the autophagy pathway intersects 
with HIV, we examined the relative distribution of HIV viri-
ons and Atg proteins. In macrophages, HIV virions are found 
in membranous domains (Gendelman et al., 1988; Raposo et al., 
2002; Pelchen-Matthews et al., 2003; Morita and Sundquist, 
conjugation systems: the Atg5-12/16 complex stimulates a sec-
ond conjugation system, whereby LC3 (Atg8) undergoes con-
version from its free C-terminus state (LC3-I) to its C-terminally 
lipidated form (LC3-II) covalently modified by phosphatidyl-
ethanolamine. The lipidated LC3-II localizes to the membrane 
of a growing phagophore. Once a phagophore closes, this results 
in the formation of a double membrane-delimited autophago-
some that typically matures into an autolysosome through fu-
sion with multivesicular body (MVB) compartments (Gruenberg 
and Stenmark, 2004) and other lysosomal organelles (Shintani 
and Klionsky, 2004). Most cells undergo baseline autophagy   
to remove protein aggregates and spuriously damaged mito-
chondria or other organelles, or to adjust the cellular biomass 
(Levine and Kroemer, 2008). With a broad range of targets, 
ranging from protein complexes to whole organelles, autoph-
agy is a process affecting a multitude of health and disease 
states; has been implicated in neurodegeneration, cancer, and 
aging (Levine and Kroemer, 2008; and has emerged as an im-
portant player in inflammatory and infectious diseases (Levine 
and Deretic, 2007; Deretic and Levine, 2009).
Autophagy is now well recognized as an innate and adap-
tive immunity mechanism (Levine and Deretic, 2007; Schmid 
and  Munz,  2007).  Pharmacologically,  physiologically,  or   
immunologically induced autophagy can act as a powerful anti-
microbial  defense  (Gutierrez  et  al.,  2004;  Nakagawa  et  al., 
2004; Ogawa et al., 2005; Birmingham et al., 2006, 2008; Singh 
et al., 2006; Levine and Deretic, 2007; Yano et al., 2008; Deretic 
and Levine, 2009). Autophagy is under the control of immune 
receptors and cytokine signaling (Levine and Deretic, 2007; 
Schmid and Munz, 2007), and is stimulated upon microbial rec-
ognition by innate immunity pattern recognition receptors (Lee 
et al., 2007; Sanjuan et al., 2007; Xu et al., 2007; Delgado et al., 
2008) or activation with Th1 cytokines (Harris et al., 2007). 
However, certain pathogens can harness this process to assist 
their own propagation (Jackson et al., 2005; Orvedahl et al., 
2007; Birmingham et al., 2008; Deretic and Levine, 2009). In-
terestingly, a recent large scale siRNA screen of host cell factors 
required for human immunodeficiency virus (HIV) type 1 (HIV-1) 
replication has identified several Atg factors among >250 HIV 
dependency host genes (Brass et al., 2008). Thus far, no in-depth 
functional links between Atg proteins or processes and HIV 
have been established.
Here, we tested mechanistically whether and how autoph-
agy affects HIV yields during de novo virion generation.   
We found that the Atg proteins LC3 and Beclin 1 (Atg6) are 
found in complexes with the HIV proteins Gag and Nef, re-
spectively. The  latter  interaction  provides  the  basis  for  Nef 
function in control of autophagy. The Nef protein of HIV-1 and 
simian immunodeficiency virus (SIV) is required for efficient 
viral replication and acquired immune deficiency syndrome 
(AIDS)  pathogenicity  in  HIV-1–infected  humans  or  SIV-
  infected macaques (Daniel et al., 1992; Deacon et al., 1995; 
Kirchhoff et al., 1995). The methods by which the Nef protein 
acts as a pathogenic factor in vivo are not fully understood, but 
involve several mechanisms (Geleziunas et al., 2001; Swingler 
et al., 2003; Peterlin, 2006; Roeth and Collins, 2006). Recent 
findings suggest that the inability of lentivirus Nef to suppress 257 HIV AND AUTOPHAGY • Kyei et al.
Biochemical analysis of HIV Gag-derived 
proteins shows copurification and 
interactions with the autophagic  
protein LC3
To determine at the biochemical level whether HIV intersects 
with the autophagy pathway, we subjected HIV-infected macro-
phages to subcellular fractionation by isopycnic centrifugation 
in sucrose gradients. Fig. 2 D shows that membranes containing 
HIV Gag polypeptides p24 and p17 cofractionated (note the co-
inciding peaks framed in Fig. 2 D) with the autophagic protein 
LC3. These membranes were enriched for the lipidated form   
of LC3, LC3-II, normally generated during engagement in an   
autophagic conjugation cascade driving autophagy initiation and 
elongation (Kabeya et al., 2000), and the recently recognized 
plasma membrane–associated autophagic events in macrophages 
2004; Deneka et al., 2007; Jouve et al., 2007) recently shown 
to  be  contiguous  with  plasma  membrane  (Jouvenet  et  al., 
2006; Deneka et al., 2007; Welsch et al., 2007), which facili-
tates colocalization studies. The Gag-p17–specific antibody 
showed  colocalization  of  the  budded  virus  with  autophagy 
marker LC3 (Atg8; Fig. 2 A). By ultrastructural analysis, HIV 
virions  were  observed  in  these  compartments  (Fig.  2  B), 
which, based on presence of clathrin-coated pits (Fig. 2 B, as-
terisk; and Fig. S1 C), were consistent with the previously re-
ported plasma membrane connections (Deneka et al., 2007). 
These morphologically identified compartments also labeled 
for LC3 (Fig. 2 C) and p24 (Fig. S1 D). A dual labeling proce-
dure was not practicable, as LC3-enhanced immunogold la-
beling  resulted  in  globular,  oval,  and  acicular  shapes,  and 
precluded clear distinction.
Figure 1.  Autophagy is required for optimal HIV yields in macrophages. (A) Pharmacological blockage of autophagy inhibits release of infectious virions. 
Human peripheral blood MDM were infected with SF162 HIV-1 for 10 d, then washed and incubated with control media or 3MA for 4.5 h. Culture super-
natants containing HIV particles were used for a MAGI infectivity assay as described in Materials and methods. (B) Relative viral release was calculated as 
a ratio of extracellular-to-intracellular Gag-derived core antigen capsid protein CA (p24) and normalized to the control. (C) Western blot showing siRNA 
knockdown of Beclin 1, 7 d after transfection in MDM. (D) Human MDM were transfected with siRNA to Beclin 1 and infected with SF162 HIV-1 for 7 d, 
then p24 yields were quantified. (E) Western blots showing siRNA knockdown of Beclin 1 and Atg7 48 h after transfection in U937 cells. (F) Knockdown of 
autophagy regulators Atg7 and Beclin 1 inhibits basal viral yields released from macrophages. U937 cells were cotransfected with Beclin 1 or Atg7 siRNA 
and pMSMBA (a clone of NL4-3). Data indicate means; error bars indicate ±SEM (n ≥ 3). *, P < 0.05; **, P < 0.01; †, P > 0.05 (analysis of variance 
[ANOVA]). (G) U937 cells were knocked down for Beclin 1 expression and infected with VSV-G–pseudotyped HIV. Cell lysates were performed for Gag 
processing analysis. *, P < 0.05, paired t test.JCB • VOLUME 186 • NUMBER 2 • 2009   258
Figure 2.  Autophagy protein LC3 colocalizes, copurifies, and coprecipitates with HIV Gag. (A) MDM were infected with VSV-G–pseudotyped HIV and 
immunostained for Gag-p17 and LC3. Arrows, a peripheral structure as an example of Gag-p17 and LC3 overlap. (B) Ultrastructural analysis of HIV 
virions in macrophages infected with HIV. U937 cells were infected with VSV-G–pseudotyped HIV. (inset) Enlarged region boxed in the electron micro-
graph. White arrow, membrane; black arrow, HIV virion; asterisk, HIV virions in a membranous compartment with a clathrin-coated pit consistent with 
plasma membrane origin. An enlarged image of this profile is shown in Fig. S1 C. (C) HIV-containing compartments are positive for LC3. Immunoelectron 
microscopy showing gold particles (enhanced gold particles appear globular, oval, and acicular) of LC3 in HIV-containing compartments. Arrow: virion 
and LC3 gold particle. See Fig. S1 D for p24 immunoelectron microscopy analysis. (D) HIV Gag precursor and Gag-derived proteins cofractionate with 
LC3 and the tetraspanin CD9. Subcellular organelle fractionation via isopycnic sucrose gradient separation was performed with lysates from HIV-infected 
cells (see Materials and methods). 12 fractions starting from the top were immunoblotted for the indicated proteins and organellar markers. The box with 
the broken line indicates peak band intensity fractions for LC3-II, Gag, and Gag-derived polypeptides, and CD9. (E) HIV Gag coimmunoprecipitates with 
LC3. U937 cells were infected with HIV and lysates immunoprecipitated for LC3. Immunoblotting with p24 and LC3 antibodies was performed on lysate 
and immunoprecipitate samples. The p24 antibody recognizes all three Gag proteins, as shown in the input. Note that only the precursor Gag-p55 comes 
down in immunoprecipitates with LC3 (n = 3).259 HIV AND AUTOPHAGY • Kyei et al.
and previous findings of inhibitory effects on viral replication of 
rapamycin in low concentrations (Heredia et al., 2003; Roy et al., 
2002), did not diminish but instead enhanced yields of the virus 
released from macrophages. The effects of autophagy induction 
appeared to be specific for macrophages, as we did not observe 
enhancement using rapamycin in HeLa or H9 T cell lines trans-
fected with an HIV molecular clone (Fig. 3 I) and H9 T cells in-
fected with the CXCR4 coreceptor using (X4, T cell tropic) 
virus HIVLAI (Fig. 3 J).
HIV protein Nef is required for  
enhanced HIV yields in response  
to autophagy induction
Given the observation that induced autophagy did not harm the 
virus, but further augmented its yields, we wondered whether the 
virus, in addition to using basal autophagy to increase its yields, 
also protected against induced autophagy, which can act as an 
antimicrobial cell-autonomous defense (Gutierrez et al., 2004; 
Nakagawa et al., 2004; Ogawa et al., 2005; Birmingham et al., 
2006, 2008; Singh et al., 2006; Levine and Deretic, 2007; Yano 
et al., 2008). We investigated whether specific HIV-1 proteins af-
fected autophagic machinery. A release of HIV deleted for nef 
was not stimulated by rapamycin in cells transfected with pNL4-
3∆Nef, as shown in Fig. 4 A, where the data were normalized to 
represent fold change in relative p24 release. These data show 
that rapamycin has no additional effect on HIV yields when the 
virus lacks Nef. The absolute levels of both the released p24 and 
cell-associated p24 were proportionately reduced with HIV∆Nef 
treated with rapamycin (Fig. 4 A, inset). As a consequence, the 
ratios remained the same (Fig. 4 A, main graph), although the 
absolute levels of p24 (both cellular and released) were dimin-
ished (Fig. 4 A, inset). In contrast to nef deletion, HIV deleted for 
vpu still responded to rapamycin stimulation with increased p24 
levels (Fig. 4 C). Furthermore, ∆Nef virus, although showing re-
duced relative release of the viral p24 (Fig. 4 C) and cellular p24 
levels (Fig. 4 D), showed no further change in yields, release, or 
cellular p24 when autophagy was inhibited by 3MA (Fig. 4 E, 
left two panels) or suppressed by Beclin 1 knockdown (Fig. 4 E, 
right two panels), indicating that Nef is critical for the detectable 
effects of autophagy on HIV.
HIV causes Nef-dependent accumulation  
of early autophagic markers
We next examined HIV effects on the execution stages of   
autophagy. The gold standard for assessment of the early execu-
tion phases of autophagy (initiation and elongation) is based on 
monitoring  biochemical  and  morphological  changes  that  the   
autophagy protein LC3 undergoes (Kabeya et al., 2000). During 
the stages when autophagic isolation membranes (phagophores) 
begin to form and nascent autophagosomes elongate until they 
are completed by closure, LC3 converts from the nonlipidated 
cytosolic species (LC3-I) to a predominantly membrane-associated 
form (LC3-II) covalently modified at the C terminus by phos-
phatidylethanolamine. During maturation stages, LC3-II is con-
sumed as a portion of it gets degraded in the autolysosomes. 
The level of LC3 lipidation is monitored by immunoblotting, 
and detected as a conversion from the unmodified LC3-I band 
(Sanjuan et al., 2007). As expected, LC3-I, the soluble cyto-
solic form of LC3, was not found on these membranes, al-
though it was detectable in whole cell lysates (Fig. S2 A). The 
LC3-II–positive membranes enriched for Gag p55, Gag pro-
cessing intermediate p41, and Gag products p24 and p17 did 
not copurify with the ER marker calnexin, but did cofractionate 
with CD9, a tetraspanin previously reported to colocalize with 
HIV virions in monocyte-derived macrophages (MDM; Fig. 2 D; 
Deneka et al., 2007).
We next tested whether HIV Gag interacted with autoph-
agy proteins in coimmunoprecipitation experiments. Fig. 2 E 
shows that LC3 is found in protein complexes with the HIV 
Gag. These findings reinforce the subcellular fractionation 
experiments  (Fig.  2  D),  are  in  keeping  with  morphological 
analyses (Fig. 2, A–C), and demonstrate that HIV components 
and virions intersect with the autophagic pathway with the   
functional consequence of augmenting Gag processing (Fig. 1 G)   
and HIV yields (Fig. 1, A–F).
Pharmacological induction of autophagy 
enhances HIV yields
We next reasoned that although the basal autophagy is required 
for optimal HIV yields, physiologically, pharmacologically, and 
immunologically induced autophagy might affect HIV yields dif-
ferently, i.e., by degrading HIV components en route to or at viral 
assembly sites. Significantly, induction of autophagy occurs during 
HIV infection of macrophages, as described previously (Delgado 
et al., 2008). Infection of primary human peripheral blood MDM 
with HIV-1 strain SF162 virus increased LC3-II levels at 10 d after 
infection (Fig. 3, A and B), which coincided with the expected 
(Prasad and Kalpana, 2009) peak HIV production in primary 
peripheral blood mononuclear cells.
To test the effects of induced autophagy, macrophages 
were treated with the conventional inducer of autophagy rapa-
mycin, and extracellular HIV yields were determined. Primary 
macrophages treated with rapamycin yielded higher p24 levels 
than untreated control when infected with the live virus or trans-
fected with a virus molecular clone (Fig. 3, C and D). The increase 
in p24 was not caused by a nonspecific leakage of cytoplasmic 
contents, as the cytosolic enzyme lactate dehydrogenase levels 
found in the medium were not altered by rapamycin treatment 
(Fig. 3 E). Similar results were obtained when two monocytic cell 
lines, THP-1 and U937, differentiated into macrophages were tested 
(Fig. 3 F). Immunoblot analyses of cell-associated viral proteins 
and p24 in virus-like particles (VLP) in culture medium indi-
cated that the increased p24 yield in macrophages treated with 
rapamycin was associated with VLP released from macrophages 
(Fig. 3 G). The autophagy machinery in these experiments was 
intact, as indicated by response to rapamycin both with LC3-I–
to–LC3-II conversion and LC3 puncta formation (Fig. S2, B–D), 
and responsiveness of the effects to inhibition with the conven-
tional autophagy inhibitor 3MA (Fig. S2, C and D). The en-
hancement effect of rapamycin on p24 release was counteracted 
by knocking down the key regulator of autophagy Atg7 (Fig. 3 H). 
Because Atg7 is a key autophagy factor, this indicates that the 
rapamycin effects on p24 are autophagy dependent. Thus, phar-
macological induction of autophagy, in contrast to our predictions JCB • VOLUME 186 • NUMBER 2 • 2009   260
cell biological studies to fully correspond both in distribution 
and function to the untagged Nef (Roeth et al., 2004). Transfec-
tion of U937 cells with Nef-DsRed2 resulted in an increased 
abundance  of  GFP-LC3  puncta  versus  the  control  DsRed2-
transfected cells (Fig. 4, H and I; and Fig. S2, E). Thus, Nef was 
responsible for accumulation of the early autophagic markers, 
the lipidated LC3-II form and LC3 puncta.
Nef inhibits autophagic maturation
The observed increase in early autophagic markers associated 
with Nef action is consistent with: (a) induction of autophagy or 
(b) a blockage of the maturation stages of autophagy. We first 
examined whether Nef affected the maturation (degradative) 
to the lipidated LC3-II form, which shows increased electro-
phoretic mobility (Kabeya et al., 2000; Mizushima and Yoshimori, 
2007). Complete HIV, but not HIV deleted for nef, increased 
levels of lipidated LC3, as reflected in the increase of LC3-II 
band on Western blots (Fig. 4 F), and LC3-II/loading control   
ratios (Mizushima and Yoshimori, 2007) using glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) as the loading reference 
(Fig. 4 G). We next used another standard assay of autophagy, 
based on fluorescence microscopy detection of LC3 on autoph-
agic membranes as punctate GFP-LC3 (LC3-II) vis-à-vis dif-
fuse cytosolic GFP-LC3 (LC3-I; Kabeya et al., 2000). U937 
cells were transfected with the previously well characterized 
expression clone of Nef-DsRed2, thoroughly documented in 
Figure 3.  Induction of autophagy enhances 
HIV  yields.  (A)  Human  peripheral  blood 
MDM  were  infected  with  SF162  HIV-1  for   
3 or 10 d, and lysates were immunoblotted 
for LC3 (one of two equal experiments shown).   
(B) Quantification: LC3-II band intensity relative 
to actin. Representative data from one of two 
independent experiments. (C and D) Induction 
of autophagy promotes viral yields from MDM. 
(C) MDM were infected with SF162 HIV for   
10 d, then washed and incubated with DMSO 
or 50 µg/ml rapamycin for 4 h. (D) MDM were 
transfected  with  a  pMSMBA  HIV  clone  for   
48 h, then washed and incubated with DMSO or   
50 µg/ml rapamycin for 4 h. Core antigen cap-
sid protein (p24) was measured as in Fig. 1.   
(E) Assessment of nonspecific cytosolic release. 
Extracellular lactate dehydrogenase (LDH) re-
lease assay was performed with a kit from Pro-
mega according to manufacturer’s instructions 
using  lysates  and  media  from  cells  treated 
with DMSO or rapamycin. Relative LDH was 
calculated as the ratio between extracellular 
and total LDH, released from MDM from two 
different  donors.  (F)  Induction  of  autophagy 
increases p24 yields in human monocytic cell 
lines. THP-1 and U937 cells differentiated into 
macrophages were transfected with pMSMBA 
for  48  h,  then  washed  and  incubated  with 
DMSO  or  rapamycin  for  4  h.  (G)  Induction   
of  autophagy  increases  release  of  VLPs  in   
human macrophages. U937 cells were infected 
with  VSV-G–pseudotyped  pMSMBA-derived 
virus for 48 h, then washed and treated for 
5  h  with  rapamycin  or  DMSO  alone.  VLPs 
were isolated on a 20% sucrose cushion, and 
lysates and VLP were immunoblotted for Gag 
and  p24,  respectively.  (H)  U937  cells  were 
cotransfected  with  siRNA  and  pMSMBA  for 
48 h, then washed and incubated with DMSO 
alone or 50 µg/ml rapamycin for 4 h. (I) HeLa 
and H9 cells were transfected with pMSMBA 
for  48  h,  then  washed  and  incubated  with 
DMSO or rapamycin for 4 h, and relative viral   
release (p24) was determined. (J) H9 cells   
(a T cell line) were infected with T cell tropic 
HIVLAI for 4 d and washed; relative viral release 
was found by determining the ratios of extra-
cellular versus intracellular reverse transcription 
levels. Data indicate means; error bars indi-
cate ±SEM (n ≥ 3). *, P < 0.05; **, P < 0.01;   
†, P > 0.05 (ANOVA).261 HIV AND AUTOPHAGY • Kyei et al.
function (Fig. S3 A). Thus, Nef inhibits terminal, degradative 
stages of autophagy.
The role of Nef in inhibiting degradative stages of autophagy 
was further examined in human cells using the RFP-GFP-LC3 
probe, a specialized tool for investigation of the autophagic flux, 
i.e., the maturation of autophagic organelles into degradative 
autolysosomal compartments (Kimura et al., 2007). Based on 
the sensitivity of GFP fluorescence to acidic pH and insensitiv-
ity of RFP fluorescence to low pH, it is possible to differentiate 
early, nonacidified autophagosomes (red
+green
+; yellow in 
merged images) from acidified, degradative autophagic organelles 
stages of the autophagic pathway. This was performed by test-
ing Nef effects on the marquee autophagic degradative func-
tion: proteolysis of long-lived, stable proteins that are normally 
turned over by autophagy. We tested whether Nef affected   
autophagic proteolysis using the published assay for stable 
protein autophagic proteolysis in macrophages, optimized and 
functional only in the mouse macrophage cell line RAW264.7 
(Roberts and Deretic, 2008). Transfection with Nef-DsRed   
did not induce autophagic proteolysis (Fig. S3 A). Instead, 
Nef-DsRed inhibited autophagic protein degradation induced 
by starvation, a gold standard for assessment of autophagy 
Figure 4.  Nef is required for yield-enhancing effects of autophagy on HIV. (A) U937 cells were transfected with pGFP-NL4-3Nef (HIVNef) for 48 h and 
incubated with DMSO or 50 µg/ml of rapamycin. (inset) Absolute values of p24 concentrations in cells (open bars) and released into the medium (shaded 
bars). Note that absolute levels of Nef virus are inhibitable by rapamycin but that the ratios of released versus cell-associated virus remain the same, as 
reflected in the main graph. (B) U937 cells were transfected with pMSMBA-vpu-null (HIV∆Vpu) and tested as in A for rapamycin effects. (C) U937 cells   
were infected with 100 ng/ml each of VSV-G–pseudotyped HIV or HIV∆Nef for 48 h, and p24 yields were quantified. (D) Absolute levels of cell-associated, 
released, and total p24 from samples in B. (E) Absence of basal autophagy inhibition effects on HIVNef yields. For experiments with 3MA, U937 cells 
were infected with NL4-3Nef for 48 h, then washed and treated for 4 h. Cells in experiments with Beclin 1 knockdowns were first transfected with 
siRNA, infected 24 h later, and harvested 48 h after infection. CTR, control. (F and G) Nef increases LC3-II (lapidated form). U937 cells were infected 
with VSV-G–pseudotyped pMSMBA-derived virus (HIV) or HIVNef for 3 d and immunoblotted for LC3. (E) Immunoblot. (F) Quantification (ratio of LC3-II 
to GAPDH band intensities). (H) U937 macrophages were cotransfected with GFP-LC3 and either DsRed2 or Nef-DsRed2 for 24 h. GFP-LC3 puncta were 
quantified in three independent experiments. (I) Quantification of LC3 puncta (≥1 µm) per cell. Data indicate means; error bars indicate ±SEM (n ≥ 3).   
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was found in immunoprecipitates generated with myc antibodies 
(Fig. 6 C). In all immunoprecipitation experiments, IgG control 
showed negative results for the specific proteins analyzed (Fig. 6). 
The blots shown with the IgG control were developed until a very 
faint band (representing background in any type of immuno-
precipitation experiments) was revealed when possible; shorter 
development times left IgG controls completely blank, whereas 
the specifically coimmunoprecipitated bands were still detected. 
Importantly, HIV Nef also coimmunoprecipitated with Beclin 1 
in extracts from cells infected with HIV virus (Fig. 6 D), demon-
strating that Nef–Beclin 1 complexes form during viral infection. 
Thus, Beclin 1 and Nef colocalize (Fig. 6 A) and are present in   
a shared protein complex (Fig. 6, B–D), associating directly or 
indirectly via an intermediate partner. Furthermore, Nef affected 
hVPS34 distribution (Fig. 6, E and F), as a consequence of its   
association with Beclin 1, resulting in an increased presence of 
hVPS34 on membranes.
Mutational analysis of HIV Nef–Beclin 1 
interactions and Nef effects on autophagy
We next used a panel of Nef mutants to test whether any of the 
known motifs were necessary for Nef interactions with Beclin 1 
and Nef effects on autophagy (Figs. 7 A and S3 G). In an identical 
coimmunoprecipitation  approach  as  in  Fig.  6,  the  previously 
characterized Nef mutant construct (Olivetta and Federico, 2006) 
with changes in the diacidic motif (
174DD
175 → 
174AA
175), respon-
sible for interactions with the V1 domain of vacuolar H
+ ATPase 
and required for CD4 down-regulation (Roeth and Collins, 2006), 
lost the capacity to coimmunoprecipitate Beclin 1 (Fig. 7 A). In 
contrast, the mutation 
154EE
155 → 
154QQ
155, in another region of 
Nef, i.e., the diacidic motif required for -COP interactions (Piguet 
et al., 1999; Roeth and Collins, 2006), did not significantly diminish 
the capacity of Nef to coimmunoprecipitate with Beclin 1   
(Fig. 7 A). Another mutation 
2G → 
2A, abrogating the ability of 
Nef to be N-terminally myristoylated, a posttranslational modifi-
cation assisting Nef in membrane localization and required for 
many Nef functions (Roeth and Collins, 2006), did not affect the 
capacity of Nef to coimmunoprecipitate with Beclin 1 (Fig. 7 A). 
Myristoylation of Nef is often considered a sine qua non post-
translational modification required for nearly all previously known 
functions of Nef (Roeth and Collins, 2006), with the exception of 
Hck activation by Nef (Briggs et al., 2001), and thus it may appear 
surprising that this did not nullify Nef’s action in our assays. 
However, it has been shown (Bentham et al., 2006) that mem-
brane association of NefG2A is not fully abrogated despite the 
loss of myristoylation, but that instead it may be shifted from 
plasma membrane to endomembranes, which is compatible with 
the action of Nef within the autophagic pathway.
The same set of Nef mutants was tested for their capacity to 
increase the LC3-II form (Fig. 7, B and C). The 
174DD
175 → 
174AA
175 
mutant was again the only Nef variant tested that resulted in   
reduced increase in the autophagic marker LC3-II. Identical results 
were obtained when expression levels of Nef mutants were ad-
justed (Fig. S3 G). Thus, based on interaction assays with Beclin 1, 
and functional analysis with LC3-I–to–LC3-II conversion, the 
diacidic motif at the positions 174 and 175 of Nef is critical for 
the ability of Nef to control autophagic flux.
(red
+green
; red in merged images; Kimura et al., 2007). In cells 
infected with Nef
+ HIV, there was a pronounced accumulation 
of red
+green
+ (yellow) puncta, compared with uninfected cells 
or cells infected with Nef HIV (Fig. 5, A–C). This is in keeping 
with the conclusion that Nef blocks maturation of early autoph-
agic organelles into acidified, degradative autolysosomes. Of the 
Nef-dependent red
+green
+ puncta, 85% were negative for the 
lysosomal protein Lamp2 (Fig. 5 D). All red
+green
 puncta 
(representing 31% of the total mRFP-GFP-LC3 puncta) were 
Lamp2 positive (Fig. 5 D). Expression of Nef-GFP resulted in 
an increase of LC3-II (Fig. 5 E). This was not or only slightly 
enhanced in the presence of bafilomycin A1 (Fig. 5 E, graph), 
an  inhibitor  of  autophagosomal/autolysosomal  acidification 
used to differentiate between effects on autophagy induction 
versus  maturation  (Mizushima  and Yoshimori,  2007),  which 
suggests that the bulk of Nef effects on autophagy were based 
on blocking autophagic flux.
Nef blocks autophagic degradation of HIV
We next tested whether Nef blocks HIV-specific autophagic 
degradation by monitoring the yields of HIV p24. U937 cells were 
infected with VSV-G–pseudotyped Nef-null HIV and treated with 
rapamycin. This led to a marked decrease in intracellular p24 
levels and in lower p24 levels in VLP preparations (Fig. 5 F). 
The decrease in p24 was abrogated with bafilomycin A1, which 
blocks autophagic degradation (Fig. 5 F). Similar results were 
observed with cellular p24 levels (Fig. 5 F). These findings 
strongly indicate that Nef inhibits autophagic degradation of 
HIV biosynthetic intermediates or virions, and that this in turn 
enhances HIV yields.
HIV Nef colocalizes with autophagy 
regulators and is found in Beclin 1  
protein complexes
We next investigated intracellular distribution of Nef in relation-
ship to autophagy regulators. Nef did not colocalize with mTOR 
(Fig. S3 B), so it is unlikely that it affects Tor directly. Nef showed 
a partial colocalization with 2xFYVE-GFP (Fig. S3 C), a probe 
binding to membranes containing phosphatidylinositol 3-phosphate 
(PI3P), the enzymatic product of type III PI3K hVPS34 that   
plays a critical role in autophagy when complexed with Beclin 1 
(Kihara et al., 2001; Furuya et al., 2005; Pattingre et al., 2005; 
Zeng et al., 2006). Nef showed colocalization with autophagy 
factors Atg7 and Atg12 (Fig. S3, D and E), and colocalized 
(Figs. 6 A and S3 F) with the autophagic protein Beclin 1, which 
is the central regulator of autophagy at multiple stages (Liang et al., 
1999; Pattingre et al., 2005). Immunoprecipitation of Beclin 1 in 
extracts from cells transfected with Nef-GFP resulted in the pres-
ence of Nef-GFP in the precipitated protein complexes (Fig. 6 B, 
top left). GFP was absent from the control samples when Beclin 1 
was immunoprecipitated from cells transfected with GFP alone 
(Fig. 6 B, top right). A converse experiment using immuno-
precipitation of GFP revealed the presence of Beclin 1 in immune 
complexes in cells transfected with Nef-GFP (Fig. 6 B, bottom 
left) but not in extracts from cells transfected with GFP alone 
(Fig. 6 B, bottom right). In a different configuration, using cells 
transfected with C-terminally myc epitope–tagged Nef, Beclin 1 263 HIV AND AUTOPHAGY • Kyei et al.
Figure 5.  Nef inhibits autophagic maturation. (A) Nef blocks maturation of early autophagic organelles into autolysosomes. 293T cells were infected with 
VSV-G–pseudotyped HIV or HIVNef and transfected with mRFP-GFP-LC3 for 48 h, then immunostained for Gag and analyzed by confocal microscopy. 
Based on differential pH sensitivity of RFP and GFP, the mRFP-GFP-LC3 probe differentiates between early, nonacidified autophagosomes (red
+green
+; 
yellow in merged images) from acidified, degradative autolysosomes (red
+green
; red in merged images). (B and C) Quantification of (red
+green
+) 
R
+G
+ and R
+G
 puncta per cell, respectively. (D) Analysis of Lamp2 association with RGP-GFP-LC3 profiles in HIV-infected 293T cells (HIV infection of 
>90% determined by staining with antibody to Gag). L
+, percentage of Lamp2-positive profiles; L
, percentage of Lamp2-negative profiles. Data are from   
42 cells from three slides. (E) LC3-II levels in Nef-transfected cells in the presence or absence of bafilomycin A1. 293T cells were transfected with GFP alone 
or Nef-GFP for 48 h. Cells were then incubated with or without bafilomycin A1 (Baf A1 or Baf) for 4 h and immunoblotted for LC3 and GAPDH. (E, bottom) 
Quantification: LC3/GAPDH ratios, representative of one of two experiments. (F) Inhibition of autophagic flux/maturation protects Nef-null virus from deg-
radation. U937 cells were infected with VSV-G–pseudotyped HIVNef for 72 h, then washed and treated with rapamycin or rapamycin plus bafilomycin A1   
(100 nM) for 5 h. VLP and cell lysates were subjected to immunoblot analysis. (F, right) Quantification of cellular p24 (n = 3). Data indicate means; error 
bars indicate ±SEM. *, P < 0.05; **, P < 0.01; †, P ≥ 0.05 (ANOVA).JCB • VOLUME 186 • NUMBER 2 • 2009   264
its function in autophagy (Orvedahl et al., 2007). However, the 
action of Nef is preferentially related to the maturation stages of 
autophagosomal pathway, as show in our work. Recent studies 
have indicated that Beclin 1–hVPS34 complexes in mammalian 
cells include potential equivalents of yeast Atg14 (Itakura et al., 
2008), which appears to be autophagy initiation specific, and 
VPS38 (UVRAG), which acts at maturation and possibly initia-
tion stages (Liang et al., 2008). Thus, different parts of the   
autophagic pathway may be targeted by viral factors affect-
ing Beclin 1: autophagy initiation or maturation as in the case of 
ICP34.5 (Orvedahl et al., 2007), and Nef (this paper). Our find-
ings also provide a functional and molecular basis for the results 
of a recent comprehensive siRNA screen in HeLa cells identify-
ing among >250 host genes several Atg factors as playing a role 
in the HIV life cycle (Brass et al., 2008).
It has been previously reported (Roy et al., 2002; Heredia 
et al., 2003) that chronic treatment (for 3–7 d) of cells with low 
concentrations of rapamycin, which do not induce autophagy, 
may inhibit viral replication. The use of rapamycin in our study 
was limited to acute doses inducing autophagy, as we used rapa-
mycin only as one of the agents to study how autophagy affects 
Discussion
This study shows that autophagy factors interact with HIV com-
ponents, that basal autophagy augments Gag processing and HIV 
yields in macrophages, and that HIV inhibits degradative stages 
of autophagy. Our data show that HIV proteins Gag and Nef   
interact with two different autophagy factors and that this con-
trols the autophagic pathway in infected cells with the net result 
of enhancing HIV yields. The rationale for our study was based 
on the growing recognition of autophagy as an antimicrobial 
cell-autonomous defense mechanism endowing eukaryotic cells 
with  the  ability  to  eliminate  invading  microbes  (Deretic  and 
Levine, 2009). However, we found that autophagy, even when 
pharmacologically induced, could not decrease HIV yields in 
macrophages, and that instead it enhanced HIV production. HIV 
protein Nef binds to the protein complexes containing the mam-
malian autophagy protein Beclin 1. Nef inhibits the degradative 
stages of the autophagy pathway, thus protecting HIV or its bio-
synthetic intermediates from autophagic destruction. The net   
effect of Nef may at first appear akin to that of herpes simplex   
virus type 1 protein ICP34.5, which binds to Beclin 1 and inhibits 
Figure 6.  Nef is in protein complexes with autophagy regula-
tor Beclin 1. (A) Macrophages were transfected with Nef-GFP 
and  immunostained  for  Beclin  1.  Arrows,  perinuclear  profiles 
exemplifying Nef and Beclin 1 colocalization. (inset) Peripheral 
colocalization. (B) 293T cells were transfected with Nef-GFP or 
GFP alone for 48 h. Lysates were immunoprecipitated either with 
Beclin 1 antibody and immunoblotted with Nef antibody (top) 
or with GFP and immunoblotted for Beclin 1 (bottom). Specific 
protein levels in cell lysates (input) and immunoprecipitates with 
IgG controls are shown. (C) Coimmunoprecipitation of Beclin 1 
with Nef-Myc. 293T cells were transfected with Nef-Myc for 48 h, 
then cells were lysed and immunoprecipitation was performed 
using monoclonal Myc antibody or IgG control. Western blots 
were probed with Beclin 1 or Nef antibodies. The blots shown 
represent one of four independent experiments. (D) U937 cells 
were infected for 48 h with VSV-G–pseudotyped HIV. Cells were 
lysed and immunoprecipitated with Beclin 1–specific antibody or 
control IgG. Western blots of immunoprecipitated material were 
probed with Nef antibody. (E and F) 293T cells were cotrans-
fected with Nef-GFP or GFP and Flag-hVPS34 for 48 h. Cells   
were fractionated into membranes (M) and cytosol (C) and immuno-
blotted with anti-Flag and Beclin 1 antibodies. (E) Immunoblots. 
(F) Quantification (ratios of membrane-associated hVPS34 to cyto-
solic hVPS34. Data indicate means; error bars indicate ±SEM.   
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stimulated for autophagy, which indicates engagement of the 
basal autophagy in biosynthesis, processing, or assembly of HIV 
intermediates. In other cell types, such as 293T cells used to 
dissect mechanistically molecular aspects of Nef action in the 
context of the autophagic pathway, the viral Gag did not show 
colocalization with the RFP-GFP-LC3 probe (Fig. 5 A), reflect-
ing the likely differences in intracellular trafficking of viral pre-
cursors in these cells versus macrophages (Gendelman et al., 
1988; Raposo et al., 2002; Pelchen-Matthews et al., 2003; Morita 
and Sundquist, 2004; Jouvenet et al., 2006; Deneka et al., 2007; 
Jouve et al., 2007; Welsch et al., 2007). Nevertheless, viral Nef 
did inhibit autophagic maturation even in 293T cells, indicating 
that this activity does not necessarily coincide with the location 
of the viral particles or Gag in relation to LC3.
This  is  further  underscored  by  the  effects  of Atg7  and   
Beclin 1 knockdowns on total p24 yields in resting macrophages 
infected with HIV. This effect has been independently observed 
in HeLa cells upon knockdown of other Atg factors (Brass et al., 
2008). The enhancement by autophagy of HIV yields coincides 
with the association of Gag with LC3 uncovered in our work. 
Furthermore, our findings of enhanced Gag processing associated 
with autophagy indicate that this process plays a role in promot-
ing certain steps in HIV biogenesis. Although autophagy is com-
monly viewed as a catabolic, degradative pathway primarily 
engaged in turning over macromolecules and removing toxic pro-
tein aggregates, or whole or parts of intracellular organelles and 
pathogens, it can also play a biosynthetic, anabolic role; this is 
clearly seen in the Cvt pathway in yeast, where Atg proteins are 
needed for completion of a functional vacuole (Scott et al., 1996; 
Xie and Klionsky, 2007)
Nef also inhibits apoptosis and cell death in macrophages 
(Olivetta and Federico, 2006). It has been shown that HIV Env   
induces death in bystander CD4
+ CXCR4
+ cells via a temporal 
succession of autophagy followed by apoptosis, and that comple-
tion of autophagy was a prerequisite for the execution of the sub-
sequent apoptotic cell death (Espert et al., 2006). This effect was   
recently narrowed down to gp41 (Denizot et al., 2008). Based on 
Nef’s ability to inhibit terminal stages of autophagy, it follows that 
Nef may protect infected macrophages against cell death, in addi-
tion to guarding virions from autophagic elimination. Extending 
viral yields, irrespective of any long term effects that rapamycin 
may have on viral replication. Furthermore, induction of autophagy 
either with rapamycin or by starvation (unpublished data) both 
increased HIV yields, provided that the virus encoded Nef. Our 
work nevertheless indicates that, when unopposed by Nef,   
autophagy can act as a cell-autonomous anti-HIV defense. This 
is likely to be of importance, as autophagy is induced during 
HIV infection, as shown here and as recently noted in the con-
text of TLR7 and TLR8 signaling (Delgado et al., 2008). In terms 
of the mechanism of the antiautophagic degradation action of 
Nef, we found that the diacidic 
174DD
175 motif, responsible for inter-
actions with the V1 domain of vacuolar H
+ ATPase and needed 
for CD4 down-regulation (Roeth and Collins, 2006), is required 
for effects of Nef on autophagy. Hence, the simplest explana-
tion would be that Nef influences H
+ ATPase assembly or activ-
ity,  precluding  autophagosomal  acidification  and  maturation 
into autolysosomes. However, although HIV inhibits acidifica-
tion of compartments with newly budded virions, the pH effect 
has been reported to be independent of Nef (Jouve et al., 2007). 
Thus, the protein complex containing Nef and Beclin 1 may act 
through a mechanism other than acidification. The effect of Nef 
on redistribution of hVPS34 (Fig. 6 E) to membranes may be 
related to inhibition of autophagic maturation.
Within the portfolio of Nef effects, which includes down-
regulation of MHC class I and CD4 cell surface expression, al-
tered T cell activation, and augmented viral infectivity (Peterlin, 
2006; Roeth and Collins, 2006; Schindler et al., 2006, 2008), a 
less understood effect is the Nef-induced accumulation of MVB-
like organelles (Stumptner-Cuvelette et al., 2003; Sandrin and 
Cosset, 2006) and emergence of large vacuoles (Sanfridson et al., 
1997). This phenomenon can now be explained at least in part   
by the inhibition of MVB or amphisome consumption due to a   
Nef-dependent blockage of autophagic degradation.
In primary human macrophages, the virus transits through 
the  intracellular  compartments  that  intersect  with  autophagy 
factors such as LC3, as illustrated in Fig. 2. The intersection   
between HIV and the autophagic pathway is not limited to con-
ditions when autophagy is induced to high levels. For example, 
the HIV precursor protein Gag is found in complexes with LC3 
(Fig. 2 E) even when macrophages are not pharmacologically 
Figure 7.  Nef 
174DD
175 motif is required for interaction with Beclin 1 and inhibition of autophagic maturation. (A) 293T cells were transfected with the 
wild-type HIV-1 Nef fusion with GFP or the indicated mutants: G
2ANefGFP, 
154EE-QQ
155NefGFP, and 
174DD-AA
175NefGFP for 48 h. Beclin 1 immunoprecipi-
tates were analyzed by immunoblotting. (B and C) 293T cells were transfected with the indicated constructs and immunoblotted for LC3. (B) Immunoblot.   
(C) Quantification (ratio of LC3-II to GAPDH band intensities). Data indicate means; error bars indicate ±SEM. *, P < 0.01; †, P ≥ 0.05 (ANOVA; n = 3).JCB • VOLUME 186 • NUMBER 2 • 2009   266
Fluorescence microscopy and image acquisition
Cells were fixed for 10 min with 1% paraformaldehyde, washed with PBS, 
and, when immunostained, permeabilized with 0.1% Triton X-100. Second-
ary antibody controls were routinely performed and showed no similarity to 
the pattern obtained when the primary antibody was included. Images were 
taken and processed on a confocal microscope system (META; Carl Zeiss, 
Inc.), equipped with 63× 1.4 NA oil differential interference contrast Plan-
Apochromat objective, using Immersol (n = 1.518) at room temperature. 
Acquisition software was LSM 510, Expert mode (Carl Zeiss, Inc.). Images 
were processed by Photoshop (Adobe) using proportional adjustments.
Electron and immunoelectron microscopy
Electron microscopy of viral budding in HIV-infected cells was performed 
as  follows:  control  or  U937  cells  infected  with  VSV-G–pseudotyped 
pMSMBA were fixed with 3% formaldehyde (from paraformaldehyde) + 2% 
glutaraldehyde in 0.1 M cacodylate, pH 7.4. Cells were then washed   
and postfixed in 1% osmium tetroxide, 100 mM cacodylate buffer; de-
hydrated with increasing concentrations of ethanol; and gradually infiltrated 
with epon resin, embedded in straight resin, and examined using a trans-
mission electron microscope (EM 900; Carl Zeiss, Inc.). Immunoelectron 
microscopy was performed using rabbit polyclonal LC3 antibody (Tanida 
et al., 2008), applying the preembedding gold enhancement method as 
described previously (Luo et al., 2006). U937 cells cultured on plastic 
coverslips (LF; Sumitomo Bakelite) were fixed with 4% paraformaldehyde   
(Nacalai Tesque) in 0.1 M sodium PBS, pH 7.4, for 30 min. After washing 
with the same buffer three times for 5 min, the fixed cells were permeabi-
lized  using  0.25%  saponin  in  PBS.  The  cells  were  washed  with  PBS, 
blocked by incubating for 30 min in PBS containing 0.1% saponin, 10% 
BSA, 10% normal goat serum, and 0.1% cold water fish skin gelatin, then 
exposed overnight to 0.01 mg/ml of anti-LC3 rabbit polyclonal antibody 
or to 0.01 mg/ml of nonimmunized rabbit IgG in the blocking solution.   
After washing with PBS containing 0.005% saponin, the cells were incu-
bated with colloidal gold (1.4-nm diameter; Nanoprobes)-conjugated goat 
anti–rabbit IgG in the blocking solution for 2 h. The cells were then washed 
with PBS and fixed with 1% glutaraldehyde in PBS for 10 min. After wash-
ing with 50 mM glycine in PBS, 1% BSA in PBS, and finally with milliQ   
water (Millipore), gold labeling was intensified with a gold enhancement 
kit (GoldEnhance EM; Nanoprobes) for 3 min at room temperature accord-
ing to the manufacturer’s instructions. After washing with distilled water, 
the cells were postfixed in 1% OsO4 containing 1.5% potassium ferrocya-
nide in PBS for 60 min at room temperature, and washed with distilled   
water. The cells were dehydrated in a series of graded ethanol solutions 
and embedded in epoxy resin. After the epoxy resin hardened, the plastic 
coverslip was removed from it. Ultrathin sections were cut horizontally to 
the cell layer and double stained with uranyl acetate and lead citrate. 
Samples were analyzed with an electron microscope (H7600; Hitachi).
Western blots and immunoprecipitations
Cells were washed in PBS and lysed with buffer containing 10 mM Tris HCl, 
pH 8.0, 150 mM NaCl, 0.5% deoxycholate, 2 mM EDTA, 2% NP-40,   
1 mM PMSF, and protease inhibitor cocktail (Roche). 50 µm of protein was 
loaded and separated on a 12.5% SDS-polyacrylamide gel and transferred 
to nitrocellulose. The membrane was blocked overnight at 4°C in 5% milk in 
PBS/Tween 20 (0.1%) and probed with primary antibodies for 1 h at room 
temperature.  After  washing  with  PBS/Tween,  the  blot  was  probed  with   
appropriate HRP-conjugated secondary antibody for 1 h at room tempera-
ture and stained with SuperSignal West Dura chemiluminescent substrate 
from Thermo Fisher Scientific. GAPDH was used as a loading control. For 
immunoprecipitations, transfected 293T cells were lysed with lysis buffer 
(50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 0.25% sodium 
deoxycholate, and 1 mM EDTA, with protease and phosphatase inhibitors) 
for 1 h, followed by centrifugation to remove cell debris. Supernatants were 
precleared and incubated for 2 h with rabbit anti–Beclin 1 (Novus Biologi-
cals), anti-LC3B, or rabbit anti-GFP (Abcam) at 4°C. The immune complexes 
were captured with protein G–agarose beads (EMD) overnight at 4°C.   
Immunoprecipitates were washed four times with PBS, eluted with Laemmli 
SDS-PAGE sample buffer for 5 min at 100°C, and subjected to immunoblot 
analysis with mouse anti-NEF (United States Biological), goat anti–Beclin 1 
(Santa Cruz Biotechnology, Inc.), and mouse anti-GFP (Abcam). Note, in 
immunoprecipitation experiments with the 
154EE
156 → 
154QQ
155 Nef mutant, 
this Nef variant consistently showed anomalous electrophoretic mobility.
Subcellular fractionation and cytosol preparation
U937 cells were infected with VSV-G–pseudotyped HIV for 2 d. Cells were 
lysed by passage through a tubing-interconnected two-syringe apparatus, 
and  nuclei  were  cleared  by  low-speed  centrifugation.  The  postnuclear   
the life span of macrophages (Olivetta and Federico, 2006) and 
protecting virions from degradation may lead to higher HIV yields 
that are important for progression to AIDS (Daniel et al., 1992; 
Kirchhoff et al., 1995). Pharmacological intervention to modulate 
autophagy in HIV-infected macrophages may help delay or prevent 
development of clinical AIDS.
Materials and methods
Cells
For macrophages, human monocytes were prepared from HIV-negative   
donors by density gradient centrifugation (400 g for 30 min) through a Ficoll-
Hypaque gradient (GE Healthcare). Adherent monocytes were matured 
into macrophages for 7 d before infection. THP-1 and U937 cells were 
maintained in RPMI supplemented with glucose, glutamine, Hepes, and 
pyruvate. HeLa and 293T cells were maintained in DME supplemented 
with glutamine and FBS. MAGI cells were obtained from the National Insti-
tutes of Health AIDS reagent program.
Antibodies and chemicals
Atg7 and Beclin 1 antibodies were obtained from Santa Cruz Biotechnology, 
Inc.; monoclonal p24 antibody was obtained from Novus Biologicals; LC3 
antibody was obtained from T. Ueno (Juntendo University School of Medi-
cine, Tokyo, Japan) or from Sigma-Aldrich, and Atg12 antibody was ob-
tained from N. Mizushima (Tokyo Metropolitan Institute of Medical Science, 
Tokyo, Japan); and the GAPDH antibody was obtained from Abcam. Gag 
monoclonal p17 and actin antibodies were obtained from Abcam. Second-
ary Alexa Fluor 488– and 568–conjugated antibodies were obtained from 
Invitrogen. Gag rabbit polyclonal antibody was obtained from the National 
Institutes of Health AIDS reagents program. Rapamycin, 3MA, bafilomycin, 
and lipopolysccharide were obtained from Sigma-Aldrich.
Autophagy methods
Autophagy was triggered by treatment with 25–50 ng/µl rapamycin for   
5 h in full nutrient medium. Alternatively, autophagy was induced by amino 
acid and serum starvation. Cells were washed three times with PBS and   
incubated in 1 ml Earle’s balanced salts solution (starvation medium) at 
37°C for 5 h. Autophagy was quantified by the GFP-LC3 puncta, LC3-I–to–
LC3-II conversion, and proteolysis assays. Autophagy was inhibited with 
10 mM 3MA. Where used, bafilomycin A1 was at a concentration of 100 nm. 
Cells were transfected or cotransfected with GFP-LC3, RFP-GFP-LC3, 
DsRed2, Nef-DsRed2 (Nef-DsRed2 was provided by K. Collins, University 
of Michigan, Ann Arbor, MI) and other constructs for 24 h. The total num-
ber of puncta (≥1 µm) per cell was counted.
HIV extracellular yield
Methods to monitor HIV p24 yields are described in the legend to Table S2. 
For experiments with H9 T cells infected with live virus, the RT-PCR–based 
assay EnzChek (Invitrogen) was used to measure reverse transcription   
activity. Assays were performed according to the manufacturer’s instruc-
tions. Relative viral release was calculated as the ratio of extracellular-to- 
intracellular reverse transcription activity (Peden et al., 1991; Fan and Peden, 
1992; Conti et al., 1998; Prasad and Kalpana, 2009).
Transfections and infections
Cells were transfected using the nucleoporation protocol (Amaxa) as de-
scribed previously (Chua and Deretic, 2004), with 10 µg of DNA or 1.5 µg 
of siRNA, as required. Atg7 and Beclin 1 knockdown protein was achieved 
using  siGENOME  SMART  pool  (Thermo  Fisher  Scientific).  All  effects  of 
siRNA were compared with siCONTROL nontargeting siRNA pool (Thermo 
Fischer Scientific). For VSV-G–pseudotyped HIV infections, U937 cells were 
differentiated overnight with 50 ng/ml of phorbol 12-myristate 13-acetate 
(Sigma-Aldrich), and viral infections were performed as described previ-
ously (Olivetta and Federico, 2006). MDM were infected with 10
5 tissue 
culture infections dose of SF162. Infections were allowed to go for 10 d with 
replacement of media every other day. Supernatants from these cells and 
cell lysates were frozen at 70°C until used for p24 ELISA or MAGI assays. 
The MAGI assay for HIV infectivity was performed as described previously 
(Chackerian et al., 1997). HIVLAI (Barre-Sinoussi et al., 1983; Nguyen et al., 
1994) was expanded for 8 d in H9 T cells as described previously (Peden 
et al., 1991). Supernatants from these cells were used to infect H9 T cells for 
experiments using titers as described in Prasad and Kalpana, (2009).267 HIV AND AUTOPHAGY • Kyei et al.
Deneka, M., A. Pelchen-Matthews, R. Byland, E. Ruiz-Mateos, and M. Marsh. 
2007.  In  macrophages,  HIV-1  assembles  into  an  intracellular  plasma 
membrane domain containing the tetraspanins CD81, CD9, and CD53. 
J. Cell Biol. 177:329–341. 
Denizot, M., M. Varbanov, L. Espert, V. Robert-Hebmann, S. Sagnier, E. Garcia, 
M. Curriu, R. Mamoun, J. Blanco, and M. Biard-Piechaczyk. 2008. 
HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells. 
Autophagy. 4:998–1008.
Deretic, V., and B. Levine. 2009. Autophagy, immunity, and microbial adapta-
tions. Cell Host and Microbe. 5:527–549.
Espert, L., M. Denizot, M. Grimaldi, V. Robert-Hebmann, B. Gay, M. Varbanov, 
P. Codogno, and M. Biard-Piechaczyk. 2006. Autophagy is involved in   
T cell death after binding of HIV-1 envelope proteins to CXCR4. J. Clin. 
Invest. 116:2161–2172. 
Fan, L., and K. Peden. 1992. Cell-free transmission of Vif mutants of HIV-1. 
Virology. 190:19–29. 
Furuya, N., J. Yu, M. Byfield, S. Pattingre, and B. Levine. 2005. The evolution-
arily conserved domain of Beclin 1 is required for Vps34 binding, autoph-
agy and tumor suppressor function. Autophagy. 1:46–52.
Geleziunas, R., W. Xu, K. Takeda, H. Ichijo, and W.C. Greene. 2001. HIV-1 Nef 
inhibits ASK1-dependent death signalling providing a potential mecha-
nism for protecting the infected host cell. Nature. 410:834–838. 
Gendelman, H.E., J.M. Orenstein, M.A. Martin, C. Ferrua, R. Mitra, T. Phipps, 
L.A. Wahl, H.C. Lane, A.S. Fauci, D.S. Burke, D. Skillman, and M.S. 
Meltzer. 1988. Efficient isolation and propagation of human immuno-
deficiency virus on recombinant colony-stimulating factor 1-treated mono-
cytes. J. Exp. Med. 167:1428–1441. 
Gruenberg, J., and H. Stenmark. 2004. The biogenesis of multivesicular endo-
somes. Nat. Rev. Mol. Cell Biol. 5:317–323. 
Gutierrez, M.G., S.S. Master, S.B. Singh, G.A. Taylor, M.I. Colombo, and V. 
Deretic. 2004. Autophagy is a defense mechanism inhibiting BCG and 
Mycobacterium  tuberculosis  survival  in  infected  macrophages.  Cell. 
119:753–766. 
Harris, J., S.A. De Haro, S.S. Master, J. Keane, E.A. Roberts, M. Delgado, and V. 
Deretic. 2007. T helper 2 cytokines inhibit autophagic control of intra-
cellular Mycobacterium tuberculosis. Immunity. 27:505–517. 
Heredia, A., A. Amoroso, C. Davis, N. Le, E. Reardon, J.K. Dominique, E. 
Klingebiel,  R.C.  Gallo,  and  R.R.  Redfield.  2003.  Rapamycin  causes 
down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: 
an approach to suppress R5 strains of HIV-1. Proc. Natl. Acad. Sci. USA. 
100:10411–10416. 
Itakura, E., C. Kishi, K. Inoue, and N. Mizushima. 2008. Beclin 1 forms two 
distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 
and UVRAG. Mol. Biol. Cell. 19:5360–5372. 
Jackson, W.T., T.H. Giddings Jr., M.P. Taylor, S. Mulinyawe, M. Rabinovitch, 
R.R. Kopito, and K. Kirkegaard. 2005. Subversion of cellular autophago-
somal machinery by RNA viruses. PLoS Biol. 3:e156. 
Jouve, M., N. Sol-Foulon, S. Watson, O. Schwartz, and P. Benaroch. 2007. HIV-1   
buds and accumulates in “nonacidic” endosomes of macrophages. Cell 
Host Microbe. 2:85–95. 
Jouvenet, N., S.J. Neil, C. Bess, M.C. Johnson, C.A. Virgen, S.M. Simon, and 
P.D. Bieniasz. 2006. Plasma membrane is the site of productive HIV-1 
particle assembly. PLoS Biol. 4:e435. 
Kabeya, Y.,  N.  Mizushima,  T.  Ueno,  A. Yamamoto,  T.  Kirisako,  T.  Noda,   
E. Kominami, Y. Ohsumi, and T. Yoshimori. 2000. LC3, a mammalian 
homologue of yeast Apg8p, is localized in autophagosome membranes 
after processing. EMBO J. 19:5720–5728. 
Kihara, A., Y. Kabeya, Y. Ohsumi, and T. Yoshimori. 2001. Beclin-phosphatidyl-
inositol 3-kinase complex functions at the trans-Golgi network. EMBO 
Rep. 2:330–335. 
Kimura, S., T. Noda, and T. Yoshimori. 2007. Dissection of the autophagosome 
maturation process by a novel reporter protein, tandem fluorescent-tagged 
LC3. Autophagy. 3:452–460.
Kirchhoff, F., T.C. Greenough, D.B. Brettler, J.L. Sullivan, and R.C. Desrosiers. 
1995. Brief report: absence of intact nef sequences in a long-term survi-
vor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332:228–232. 
Klionsky, D.J. 2007. Autophagy: from phenomenology to molecular understand-
ing in less than a decade. Nat. Rev. Mol. Cell Biol. 8:931–937. 
Lee, H.K., J.M. Lund, B. Ramanathan, N. Mizushima, and A. Iwasaki. 2007. 
Autophagy-dependent viral recognition by plasmacytoid dendritic cells. 
Science. 315:1398–1401. 
Levine, B., and V. Deretic. 2007. Unveiling the roles of autophagy in innate and 
adaptive immunity. Nat. Rev. Immunol. 7:767–777. 
Levine, B., and D.J. Klionsky. 2004. Development by self-digestion: mo-
lecular mechanisms and biological functions of autophagy. Dev. Cell. 
6:463–477. 
supernatant was put on 20, 30, 40, 45, 50, 55, and 60% sucrose gradi-
ents, then centrifuged overnight at 100,000 g. 12 fractions collected from 
the top were pelleted at 100,000 g for 1 h and immunoblotted for the indi-
cated organellar markers.
Online supplemental material
Fig.  S1  shows  that  Atg7  and  Beclin  1  knockdowns  inhibit  autophagy 
in U937 cells, as well as transmission and immunoelectron micrograph 
HIV profiles in macrophages. Fig. S2 shows a comparison of LC3 forms 
in whole cell lysate versus LC3 forms associated with membranes, that 
autophagy  induction  is  operational  in  cells  used  to  detect  HIV  yield- 
enhancing  effects  of  acute  rapamycin  treatment,  and  that  Nef  causes   
accumulation of LC3 puncta. Fig. S3 shows that Nef inhibits autophagic 
proteolysis;  intracellular  localization  of  Nef  relative  to  mTor,  2xFYVE-
GFP, and autophagy markers Atg7, Atg12, and Beclin 1; and that Nef   
motif 
174DD
175 is but G
2A motif is not required for Nef-dependent increase 
in LC3II levels. Table S1 shows HIV molecular clones, viruses, and viral 
preparations and use. Table S2 shows ELISA (p24) and quantification of 
viral release. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.200903070/DC1.
We thank N. Mizushima for Atg12 antibody, K. Collins for Nef clones,   
T. Howard and the electron microscopy facility for assistance, and M. Peterlin 
for discussion.
This work was supported by National Institute of Allergy and Infectious 
Diseases grants AI069345, AI45148, AI42999 to V. Deretic, AI06849 to   
L. Wu, and by amfAR grant 107160-44-RGRL and a Bill and Melinda Gates 
Foundation Grand Challenges Explorations grant G#52068 to V. Deretic.   
C. Dinkins was supported by National Institutes of Health Biology of Infectious 
Diseases and Inflammation training grant T32AI007538.
Submitted: 13 March 2009
Accepted: 1 July 2009
References
Barre-Sinoussi, F., J.C. Chermann, F. Rey, M.T. Nugeyre, S. Chamaret, J. Gruest, 
C. Dauguet, C. Axler-Blin, F. Vezinet-Brun, C. Rouzioux, et al. 1983. 
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired 
immune deficiency syndrome (AIDS). Science. 220:868–871. 
Bentham, M., S. Mazaleyrat, and M. Harris. 2006. Role of myristoylation and 
N-terminal basic residues in membrane association of the human immuno-
deficiency virus type 1 Nef protein. J. Gen. Virol. 87:563–571. 
Birmingham, C.L., A.C. Smith, M.A. Bakowski, T. Yoshimori, and J.H. Brumell. 
2006. Autophagy controls Salmonella infection in response to damage to 
the Salmonella-containing vacuole. J. Biol. Chem. 281:11374–11383.
Birmingham, C.L., V. Canadien, N.A. Kaniuk, B.E. Steinberg, D.E. Higgins, and 
J.H. Brumell. 2008. Listeriolysin O allows Listeria monocytogenes repli-
cation in macrophage vacuoles. Nature. 451:350–354. 
Brass, A.L., D.M. Dykxhoorn, Y. Benita, N. Yan, A. Engelman, R.J. Xavier, 
J.  Lieberman,  and  S.J.  Elledge.  2008.  Identification  of  host  proteins   
required for HIV infection through a functional genomic screen. Science. 
319:921–926. 
Briggs,  S.D.,  B.  Scholtz,  J.M.  Jacque,  S.  Swingler,  M.  Stevenson,  and T.E. 
Smithgall. 2001. HIV-1 Nef promotes survival of myeloid cells by a 
Stat3-dependent pathway. J. Biol. Chem. 276:25605–25611. 
Chackerian,  B.,  E.M.  Long,  P.A.  Luciw,  and  J.  Overbaugh.  1997.  Human   
immunodeficiency virus type 1 coreceptors participate in postentry stages 
in the virus replication cycle and function in simian immunodeficiency   
virus infection. J. Virol. 71:3932–3939.
Chua, J., and V. Deretic. 2004. Mycobacterium tuberculosis reprograms waves 
of phosphatidylinositol 3-phosphate on phagosomal organelles. J. Biol. 
Chem. 279:36982–36992. 
Conti, L., G. Rainaldi, P. Matarrese, B. Varano, R. Rivabene, S. Columba, A. 
Sato, F. Belardelli, W. Malorni, and S. Gessani. 1998. The HIV-1 vpr pro-
tein acts as a negative regulator of apoptosis in a human lymphoblastoid 
T cell line: possible implications for the pathogenesis of AIDS. J. Exp. 
Med. 187:403–413. 
Daniel, M.D., F. Kirchhoff, S.C. Czajak, P.K. Sehgal, and R.C. Desrosiers. 1992. 
Protective effects of a live attenuated SIV vaccine with a deletion in the 
nef gene. Science. 258:1938–1941. 
Deacon,  N.J., A. Tsykin, A.  Solomon,  K.  Smith,  M.  Ludford-Menting,  D.J. 
Hooker, D.A. McPhee, A.L. Greenway, A. Ellett, C. Chatfield, et al. 1995. 
Genomic structure of an attenuated quasi species of HIV-1 from a blood 
transfusion donor and recipients. Science. 270:988–991. 
Delgado, M.A., R.A. Elmaoued, A.S. Davis, G. Kyei, and V. Deretic. 2008. Toll-
like receptors control autophagy. EMBO J. 27:1110–1121. JCB • VOLUME 186 • NUMBER 2 • 2009   268
Schindler, M., J. Munch, O. Kutsch, H. Li, M.L. Santiago, F. Bibollet-Ruche, 
M.C. Muller-Trutwin, F.J. Novembre, M. Peeters, V. Courgnaud, et al. 
2006. Nef-mediated suppression of T cell activation was lost in a lenti-
viral lineage that gave rise to HIV-1. Cell. 125:1055–1067. 
Schindler, M., J. Schmokel, A. Specht, H. Li, J. Munch, M. Khalid, D.L. Sodora, 
B.H. Hahn, G. Silvestri, and F. Kirchhoff. 2008. Inefficient Nef-mediated 
downmodulation of CD3 and MHC-I correlates with loss of CD4+T cells 
in natural SIV infection. PLoS Pathog. 4:e1000107. 
Schmid, D., and C. Munz. 2007. Innate and adaptive immunity through autoph-
agy. Immunity. 27:11–21. 
Schmid, D., M. Pypaert, and C. Munz. 2007. Antigen-loading compartments for 
major histocompatibility complex class II molecules continuously receive 
input from autophagosomes. Immunity. 26:79–92. 
Scott, S.V., A. Hefner-Gravink, K.A. Morano, T. Noda, Y. Ohsumi, and D.J. 
Klionsky. 1996. Cytoplasm-to-vacuole targeting and autophagy employ 
the same machinery to deliver proteins to the yeast vacuole. Proc. Natl. 
Acad. Sci. USA. 93:12304–12308. 
Shintani, T., and D.J. Klionsky. 2004. Autophagy in health and disease: a double-
edged sword. Science. 306:990–995. 
Singh, S.B., A.S. Davis, G.A. Taylor, and V. Deretic. 2006. Human IRGM induces 
autophagy to eliminate intracellular mycobacteria. Science. 313:1438–1441. 
Stumptner-Cuvelette, P., M. Jouve, J. Helft, M. Dugast, A.S. Glouzman, K. Jooss, 
G. Raposo, and P. Benaroch. 2003. Human immunodeficiency virus-1 
Nef expression induces intracellular accumulation of multivesicular bod-
ies and major histocompatibility complex class II complexes: potential 
role of phosphatidylinositol 3-kinase. Mol. Biol. Cell. 14:4857–4870. 
Swingler, S., B. Brichacek, J.M. Jacque, C. Ulich, J. Zhou, and M. Stevenson. 
2003. HIV-1 Nef intersects the macrophage CD40L signalling pathway to 
promote resting-cell infection. Nature. 424:213–219. 
Tanida, I., T. Ueno, and E. Kominami. 2008. LC3 and Autophagy. Methods Mol. 
Biol. 445:77–88. 
Welsch, S., O.T. Keppler, A. Habermann, I. Allespach, J. Krijnse-Locker, and 
H.G. Krausslich. 2007. HIV-1 buds predominantly at the plasma mem-
brane of primary human macrophages. PLoS Pathog. 3:e36. 
Xie, Z., and D.J. Klionsky. 2007. Autophagosome formation: core machinery 
and adaptations. Nat. Cell Biol. 9:1102–1109. 
Xu, Y., C. Jagannath, X.D. Liu, A. Sharafkhaneh, K.E. Kolodziejska, and N.T. 
Eissa. 2007. Toll-like receptor 4 is a sensor for autophagy associated with 
innate immunity. Immunity. 27:135–144. 
Yano, T., S. Mita, H. Ohmori, Y. Oshima, Y. Fujimoto, R. Ueda, H. Takada, W.E. 
Goldman, K. Fukase, N. Silverman, et al. 2008. Autophagic control of 
listeria through intracellular innate immune recognition in drosophila. 
Nat. Immunol. 9:908–916. 
Zeng, X., J.H. Overmeyer, and W.A. Maltese. 2006. Functional specificity of the 
mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus 
endocytosis and lysosomal enzyme trafficking. J. Cell Sci. 119:259–270. 
Levine, B., and G. Kroemer. 2008. Autophagy in the pathogenesis of disease. 
Cell. 132:27–42. 
Liang, C., J.S. Lee, K.S. Inn, M.U. Gack, Q. Li, E.A. Roberts, I. Vergne, V. 
Deretic,  P.  Feng,  C. Akazawa,  and  J.U.  Jung.  2008.  Beclin1-binding 
UVRAG targets the class C Vps complex to coordinate autophagosome 
maturation and endocytic trafficking. Nat. Cell Biol. 10:776–787. 
Liang, X.H., S. Jackson, M. Seaman, K. Brown, B. Kempkes, H. Hibshoosh, and 
B. Levine. 1999. Induction of autophagy and inhibition of tumorigenesis 
by beclin 1. Nature. 402:672–676. 
Luo, H., F. Nakatsu, A. Furuno, H. Kato, A. Yamamoto, and H. Ohno. 2006. 
Visualization of the post-Golgi trafficking of multiphoton photoactivated 
transferrin receptors. Cell Struct. Funct. 31:63–75. 
Mizushima, N., and T. Yoshimori. 2007. How to interpret LC3 immunoblotting. 
Autophagy. 3:542–545.
Morita, E., and W.I. Sundquist. 2004. Retrovirus budding. Annu. Rev. Cell Dev. 
Biol. 20:395–425. 
Nakagawa, I., A. Amano, N. Mizushima, A. Yamamoto, H. Yamaguchi, T. Kamimoto, 
A. Nara, J. Funao, M. Nakata, K. Tsuda, et al. 2004. Autophagy defends 
cells against invading group A Streptococcus. Science. 306:1037–1040. 
Nguyen, M.H., R.F. Schinazi, C. Shi, N.M. Goudgaon, P.M. McKenna, and J.W. 
Mellors. 1994. Resistance of human immunodeficiency virus type 1 to 
acyclic 6-phenylselenenyl- and 6-phenylthiopyrimidines. Antimicrob. 
Agents Chemother. 38:2409–2414.
Ogawa, M., T.  Yoshimori, T. Suzuki, H. Sagara, N. Mizushima, and C. Sasakawa. 2005. 
Escape of intracellular Shigella from autophagy. Science. 307:727–731. 
Olivetta, E., and M. Federico. 2006. HIV-1 Nef protects human-monocyte-derived 
macrophages from HIV-1-induced apoptosis. Exp. Cell Res. 312:890–900. 
Ono, A., and E.O. Freed. 2004. Cell-type-dependent targeting of human immuno-
deficiency virus type 1 assembly to the plasma membrane and the multi-
vesicular body. J. Virol. 78:1552–1563. 
Orvedahl, A., D. Alexander, Z. Talloczy, Q. Sun, Y. Wei, W. Zhang, D. Burns, 
D.A.  Leib,  and  B.  Levine.  2007.  HSV-1  ICP34.5  confers  neuro-
virulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe. 
1:23–35. 
Pattingre, S., A. Tassa, X. Qu, R. Garuti, X.H. Liang, N. Mizushima, M. Packer, 
M.D. Schneider, and B. Levine. 2005. Bcl-2 antiapoptotic proteins inhibit 
Beclin 1-dependent autophagy. Cell. 122:927–939. 
Peden, K., M. Emerman, and L. Montagnier. 1991. Changes in growth prop-
erties  on  passage  in  tissue  culture  of  viruses  derived  from  infectious 
molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology. 
185:661–672. 
Pelchen-Matthews, A., B. Kramer, and M. Marsh. 2003. Infectious HIV-1 assembles 
in late endosomes in primary macrophages. J. Cell Biol. 162:443–455. 
Peterlin, B.M. 2006. Nef: out and in? Nat. Immunol. 7:229–230. 
Piguet, V., F. Gu, M. Foti, N. Demaurex, J. Gruenberg, J.L. Carpentier, and D. 
Trono. 1999. Nef-induced CD4 degradation: a diacidic-based motif in 
Nef functions as a lysosomal targeting signal through the binding of beta-
COP in endosomes. Cell. 97:63–73. 
Prasad, V.R., and G.V. Kalpana. 2009. HIV protocols. Humana Press, New York. 
457 pp.
Raposo, G., M. Moore, D. Innes, R. Leijendekker, A. Leigh-Brown, P. Benaroch, 
and H. Geuze. 2002. Human macrophages accumulate HIV-1 particles in 
MHC II compartments. Traffic. 3:718–729. 
Roberts, E.A., and V. Deretic. 2008. Autophagic proteolysis of long-lived pro-
teins in nonliver cells. Methods Mol. Biol. 445:111–117. 
Roeth, J.F., and K.L. Collins. 2006. Human immunodeficiency virus type 1 Nef: 
adapting to intracellular trafficking pathways. Microbiol. Mol. Biol. Rev. 
70:548–563. 
Roeth, J.F., M. Williams, M.R. Kasper, T.M. Filzen, and K.L. Collins. 2004. 
HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I 
cytoplasmic tail. J. Cell Biol. 167:903–913. 
Roy, J., J.S. Paquette, J.F. Fortin, and M.J. Tremblay. 2002. The immunosuppres-
sant rapamycin represses human immunodeficiency virus type 1 replica-
tion. Antimicrob. Agents Chemother. 46:3447–3455. 
Sandrin, V., and F.L. Cosset. 2006. Intracellular versus cell surface assembly of 
retroviral pseudotypes is determined by the cellular localization of the 
viral glycoprotein, its capacity to interact with Gag, and the expression of 
the Nef protein. J. Biol. Chem. 281:528–542. 
Sanfridson, A., S. Hester, and C. Doyle. 1997. Nef proteins encoded by human   
and  simian  immunodeficiency  viruses  induce  the  accumulation  of   
endosomes and lysosomes in human T cells. Proc. Natl. Acad. Sci. USA. 
94:873–878. 
Sanjuan, M.A., C.P. Dillon, S.W. Tait, S. Moshiach, F. Dorsey, S. Connell, M. 
Komatsu, K. Tanaka, J.L. Cleveland, S. Withoff, and D.R. Green. 2007. 
Toll-like receptor signalling in macrophages links the autophagy pathway 
to phagocytosis. Nature. 450:1253–1257. 